大成生化科技(00809.HK):根據法院執行裁定書出售土地
格隆匯11月12日丨大成生化科技(00809.HK)發佈公吿,公司全資附屬公司哈爾濱大成生物科技有限公司(“哈爾濱大成”)已收到吉林省長春市中級人民法院發出的執行裁定書。執行裁定書是由於哈爾濱大成未能履行調解令而發出,該調解令要求哈爾濱大成須向公司全資附屬公司長春大合生物科技發展有限公司(“長春大合”)償還長春大合向哈爾濱大成提供的違約貸款。該筆違約貸款的本金金額連同利息、罰款及訴訟費用於2021年10月31日合共約為人民幣3.163億元。
根據執行裁定書,法院已頒令哈爾濱大成須透過網絡平台進行司法公開拍賣的方式,出售其於位於黑龍江省賓縣賓西經濟開發區的部分土地(包括其上的樓宇及結構、配套設施及機械設備)的權益,以清償有關申索。該土地為哈爾濱大成生產基地的一部分,總面積約為39萬平方米,其於2021年6月30日的總賬面值約為人民幣2.565億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.